BIO
Bio-Rad Laboratories margins
- Stocks
- Healthcare
- NYSE: BIO
- Margins
For this period, Bio-Rad Laboratories reports a gross margin of 51.9%, an operating margin of 2.1%, an EBITDA margin of 15.4%, and a net margin of 8.6%. Each available margin weakened from the same period last year. Operating margin recorded the strongest contraction, falling by 6.7 percentage points.
BIO margin history
Bio-Rad Laboratories's margins averaged 53.02% gross, 8.53% operating, -26.25% EBITDA, and -22.25% net during the last 3 years. Against the three-year averages, EBITDA and net margins are above their three-year averages and gross and operating margins are below their three-year averages.
BIO margin expansion
The biggest contraction was in operating margin, which fell by 6.7 percentage points. The other available margins also declined.
BIO Gross margin
Looking back over the last 3 years, Bio-Rad Laboratories recorded an average gross margin of 53.02%. Bio-Rad Laboratories's current gross margin is 51.9% and is 1.1 percentage points below its three-year average. The highest gross margin for Bio-Rad Laboratories was 54.4% in Sep 2024, while the lowest was 51.9% in Dec 2025.
BIO Operating margin
Over the last 3 years, the average operating margin for Bio-Rad Laboratories was 8.53%. The current operating margin stands at 2.1%, 6.4 percentage points below its three-year average. Bio-Rad Laboratories's operating margin ranged from a low of 1.8% in Dec 2025 to a high of 13% in Jun 2024.
BIO EBITDA margin
Bio-Rad Laboratories recorded an average EBITDA margin of -26.25% across the last 3 years. Bio-Rad Laboratories currently reports an EBITDA margin of 15.4%, 41.7 percentage points above its three-year average. Looking back over the last 3 years, Bio-Rad Laboratories's EBITDA margin reached 40.4% at its highest point in Dec 2025 and -106.3% at its lowest in Mar 2025.
BIO Net margin
Over the last 3 years, Bio-Rad Laboratories's net margin averaged -22.25%. Right now, Bio-Rad Laboratories's current net margin is 8.6%, which is 30.9 percentage points above its three-year average. During this period, net margin reached a high of 29.4% in Dec 2025 and a low of -85.2% in Mar 2025.
BIO margin group comparison
With a gross margin of 51.9%, BIO ranks higher than its peers average but lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 68.4%, Bio-Rad Laboratories's gross margin is 24% lower.
BIO margin peer comparison
Frequently asked questions
What is Bio-Rad Laboratories's gross margin?
As of Jun 30, 2026, BIO has a gross margin of 51.9%.
What is Bio-Rad Laboratories's operating margin?
For the period ending Jun 30, 2026, BIO recorded an operating margin of 2.1%.
What is Bio-Rad Laboratories's EBITDA margin?
The current EBITDA margin for BIO is 15.4% as of Jun 30, 2026.
What is Bio-Rad Laboratories's net margin?
As of Jun 30, 2026, BIO has a net margin of 8.6%.
What are the average margins of BIO?
Looking back over 3 years, BIO recorded average margins of 53.0% gross, 8.5% operating, -26.3% EBITDA, and -22.3% net.
What are the highest historical margins of BIO?
Within the 5-year period, BIO recorded its highest margins at 56.9% gross in Jun 2022, 18.9% operating in Jun 2022, 186.5% EBITDA in Dec 2021, and 145.6% net in Dec 2021.
What are the lowest historical margins of BIO?
Within the 5-year period, BIO recorded its lowest margins at 51.9% gross in Dec 2025, 1.8% operating in Dec 2025, -278% EBITDA in Sep 2022, and -214.7% net in Sep 2022.